Literature DB >> 30298907

Tuberous sclerosis-associated neuropsychiatric disorders: a paediatric cohort study.

Irene Toldo1, Valeria Brasson1, Marina Miscioscia1,2, Maria Federica Pelizza1, Renzo Manara3, Stefano Sartori1, Giulia Mantegazza4, Marilena Vecchi1, Margherita Nosadini1, Michela Gatta1.   

Abstract

AIM: We aimed to study tuberous sclerosis-associated neuropsychiatric disorders (TAND) in children and adolescents with tuberous sclerosis complex (TSC).
METHOD: Retrospective and prospective cohort study conducted at a Paediatric Neurology Unit of an Italian Tertiary Care Hospital. Clinical and neuroimaging data were reviewed. Scores for neurological and epilepsy outcomes (Extended Glasgow Outcome Scale, Paediatric Version and Early Childhood Epilepsy Severity Scale modified), semi-structured interviews (authorized Italian version of the TAND checklist and Vineland Adaptive Behavior Scales) and questionnaires (Child Behavior Checklist [CBCL]) were applied at last follow-up.
RESULTS: Thirty-two patients with TSC (age range 1-19y) were enrolled. Eighty-eight per cent had at least one TAND and 47% had intellectual disability. The TAND checklist showed internalizing problems in 25.8% of cases (vs 41.9% by CBCL), and externalizing problems in 41.9% (vs 9.7% by CBCL). TAND prevailed in patients with de novo mutation of TSC2, high tuber load, and severe neurological and epilepsy outcomes.
INTERPRETATION: In our cohort, 78% of patients had more than four TAND behavioural problems; nevertheless, they did not show a constant and specific neuropsychiatric profile. Clinical, neurophysiological, and neuroradiological features were associated with several TAND. The TAND checklist appeared more effective than the CBCL, particularly in detecting externalizing problems. WHAT THIS PAPER ADDS: The Tuberous sclerosis-associated neuropsychiatric disorders (TAND) checklist is an effective tool for TAND screening. The TAND checklist helps define psychopathological and neuropsychiatric aspects in paediatric patients with Tuberous sclerosis complex (TSC). TAND were found in 88% of patients with TSC, whilst 78% had more than four TAND. TAND distribution depends on different clinical and neuroradiological features.
© 2018 Mac Keith Press.

Entities:  

Mesh:

Year:  2018        PMID: 30298907     DOI: 10.1111/dmcn.14055

Source DB:  PubMed          Journal:  Dev Med Child Neurol        ISSN: 0012-1622            Impact factor:   5.449


  8 in total

1.  The Phenotypic Spectrum of Tuberous Sclerosis Complex: A Canadian Cohort.

Authors:  Daad Alsowat; Robyn Whitney; Stacy Hewson; Puneet Jain; Valerie Chan; Nadia Kabir; Kimberly Amburgey; Damien Noone; Mathieu Lemaire; Blathnaid McCoy; Maria Zak
Journal:  Child Neurol Open       Date:  2021-05-04

Review 2.  A systematic review on the burden of illness in individuals with tuberous sclerosis complex (TSC).

Authors:  Johann Philipp Zöllner; David Neal Franz; Christoph Hertzberg; Rima Nabbout; Felix Rosenow; Matthias Sauter; Susanne Schubert-Bast; Adelheid Wiemer-Kruel; Adam Strzelczyk
Journal:  Orphanet J Rare Dis       Date:  2020-01-21       Impact factor: 4.123

3.  Assessment of tuberous sclerosis-associated neuropsychiatric disorders using the MINI-KID tool: a pediatric case-control study.

Authors:  Yifeng Ding; Ji Wang; Hao Zhou; Taoli Li; Shuizhen Zhou; Yi Wang
Journal:  Orphanet J Rare Dis       Date:  2021-04-17       Impact factor: 4.123

4.  Tanc2-mediated mTOR inhibition balances mTORC1/2 signaling in the developing mouse brain and human neurons.

Authors:  Sun-Gyun Kim; Suho Lee; Yangsik Kim; Jieun Park; Doyeon Woo; Dayeon Kim; Yan Li; Wangyong Shin; Hyunjeong Kang; Chaehyun Yook; Minji Lee; Kyungdeok Kim; Junyeop Daniel Roh; Jeseung Ryu; Hwajin Jung; Seung Min Um; Esther Yang; Hyun Kim; Jinju Han; Won Do Heo; Eunjoon Kim
Journal:  Nat Commun       Date:  2021-05-11       Impact factor: 14.919

Review 5.  The research landscape of tuberous sclerosis complex-associated neuropsychiatric disorders (TAND)-a comprehensive scoping review.

Authors:  Stephanie Vanclooster; Stacey Bissell; Agnies M van Eeghen; Nola Chambers; Liesbeth De Waele; Anna W Byars; Jamie K Capal; Sebastián Cukier; Peter Davis; Jennifer Flinn; Sugnet Gardner-Lubbe; Tanjala Gipson; Tosca-Marie Heunis; Dena Hook; J Christopher Kingswood; Darcy A Krueger; Aubrey J Kumm; Mustafa Sahin; Eva Schoeters; Catherine Smith; Shoba Srivastava; Megumi Takei; Robert Waltereit; Anna C Jansen; Petrus J de Vries
Journal:  J Neurodev Disord       Date:  2022-02-13       Impact factor: 4.025

6.  Symptom rates and profile clustering in tuberous sclerosis complex-associated neuropsychiatric disorders (TAND).

Authors:  Samuel Alperin; Darcy A Krueger; David N Franz; Karen D Agricola; Gabrielle Stires; Paul S Horn; Jamie K Capal
Journal:  J Neurodev Disord       Date:  2021-12-13       Impact factor: 4.025

7.  The TAND checklist: a useful screening tool in children with tuberous sclerosis and neurofibromatosis type 1.

Authors:  Francesca Cervi; Veronica Saletti; Katherine Turner; Angela Peron; Sara Bulgheroni; Matilde Taddei; Francesca La Briola; Maria Paola Canevini; Aglaia Vignoli
Journal:  Orphanet J Rare Dis       Date:  2020-09-07       Impact factor: 4.123

8.  Quality of life in children with tuberous sclerosis complex: A pediatric cohort study.

Authors:  Yifeng Ding; Ji Wang; Yuanfeng Zhou; Lifei Yu; Linmei Zhang; Shuizhen Zhou; Yi Wang
Journal:  CNS Neurosci Ther       Date:  2020-11-23       Impact factor: 5.243

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.